Comprehensive Analysis of Cetuximab Critical Quality Attributes: Impact of Handling on Antigen-Antibody Binding

• Main Authors: Alicia Torres-García (Author), Anabel Torrente-López (Author), Jesús Hermosilla (Author), Amparo Hernández (Author), Antonio Salmerón-García (Author), José Cabeza (Author), Natalia Navas (Author)
• Format: Book
• Published: MDPI AG, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background/Objectives: Cetuximab, formulated in Erbitux^® (5 mg/mL), is a therapeutic monoclonal antibody (mAb) widely used in several cancer treatments. Currently, there is insufficient knowledge about the behavior of cetuximab with regard to the risk associated with its routi...